Responsible for oversight of Spannerwerks Consulting Associates, client PM lead on R&D programs, providing strategic and operational solutions to biopharmaceutical clients. Provides leadership, integrated program management, and execution to biopharmaceutical companies in critical periods of growth.

Provide strategic and operational services to Biopharmaceutical companies. Areas of focus include the creation of program development plans, timelines and budgets; portfolio management processes; and strategic planning.Experience includes working with start-up virtual and established Biotech companies with global R&D activities. Instrumental in developing and implementing program and portfolio development plans, budgets, timelines, and the preparation of BOD materials. Responsible for developing and managing relationships with CROs and CMOs to implement lead and follow-on projects. Recent accomplishments include working with a client to manage the compilation of Module 3 (Quality) for their BLA for a novel ADC, and submission of an IND for an oncology monclonal antibody treatment.

Kirilys is a private, multi-asset, clinical-stage oncology company founded by investment firm Catalys Pacific.

Senior Director, Portfolio and Program Management 2014-2015Senior Director, Head of Program & Alliance Management 2012-2013Director, Head of Program Management 2007-2012Associate Director, Head of Program Management 2006-2007Responsible for building and managing the portfolio, program and alliance management functions at Seattle Genetics. Adapted decision-making process processes to scale as the company grew from an R&D company to a commercial company.● Portfolio Management / Strategic Planning: Developed internal processes for portfolio management, focused on aligning corporate vision with program development options and availability of resources. Created a resource planning model to understand resource implications for different portfolio options. ● Reporting: Developed the quarterly program dashboard report for distribution to senior management and Board of Directors. Drove the process to create the research and program presentations for the quarterly Board of Directors meeting.● Alliance Management: In 2012, Alliance Management moved from Business Development into my group (Program Management), to ensure close management of relationships with major Biotech/Biopharmaceutical companies that licensed Seattle Genetics technology. These companies are an important revenue stream for milestone payments and potential future royalties for Seattle Genetics.● Budgeting / Planning: Developed corporate assumptions for each program with senior management to aid in the development of a coordinated corporate budget and long range plan. Reviewed and assessed line item and headcount budget submissions for each program. ● Staff Development: Hired a strong team of program managers. Drove goal setting process with staff; provided guidance on communication, presentation style and effective management of team dynamics. Hired, trained and retained key staff.

Associate Director, Head of Corporate Project Management 2005-2006Neuvenge Project Manager 2003-2006● Portfolio Management / Strategic Planning: Developed and led the first process, working with Business Development and Research teams to assess and prioritize internal candidates. Conducted due diligence for potential in-license clinical candidates, including development plans, risk assessments and valuation estimates.● Project Reviews: Designed and implemented a formal R&D Project Review process. Project review outcomes were utilized in the annual and long range planning processes.● Best Practices: Developed the department’s charter and project management roles and responsibilities; provided guidance and oversight on project management best practices to other departments.● Training: Designed and conducted project team training for the Provenge and Neuvenge project teams; contracted with professional facilitators for training delivery.● Reporting: Developed the corporate Key Performance Indicator reporting format; distributed reports and frequent project status updates to senior management; created reports for the Board of Directors on progress towards corporate goals.● Budgeting / Planning: Developed key corporate assumptions by project with key functional managers to aid the development of a coordinated corporate budget and long range plan; reviewed and assessed line item and headcount budget submissions for specific projects.● Staff Development: Drove quarterly goal setting process with project management staff; provided guidance on communication, presentation style and effective management of difficult team dynamics.Neuvenge Project Manager:Led the product development team for the breast cancer immunotherapy candidate, Neuvenge. Created product development timelines, set project meeting agendas, tracked action items and team goals/milestones.

Associate Director, Team Leader, Product Development 2002-2003Led product development team project planning activities for IC485, a small molecule inhibitor of phosphodiesterase 4 (PDE4), for the treatment of chronic obstructive pulmonary disease (COPD). Responsible for the creation of Quarterly Review documentation. ● Created weekly project summary documents● Drove budget and forecast estimates; created monthly project expense variance reports● Developed risk mitigation plans● Interacted with investment analysts and communicated project plans to potential business partners● Laid the groundwork for initiating multi-country European Phase 2 study Senior Manager, Product Development – ICOS joint venture with Eli Lilly 1999-2002Managed the joint project team for Cialis, a phosphodiesterase 5 (PDE5) small molecule inhibitor to treat erectile dysfunction. ● Conducted risk mitigation and scenario planning● Collaborated on the U.S. product insert (USPI) and summary of product characteristics (SPC) documents for registration in U.S. and Europe● Contributed to the Global Launch Team● Led an aggressive program schedule and achieved simultaneous US NDA and European MAA submissions, resulting in approval and successful global launch of Cialis in 2003● Conducted scientific and market assessments to create the Cialis life cycle management plan

Senior Project Manager 1997-1999Senior Project Coordinator 1995-1997Led multiple vaccine development cross-functional core teams, including Human Papilloma Virus (HPV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV) from preclinical through Phase 2. ● Prepared development plans, managed project time lines and budgets, and prepared project assessments for portfolio management● Managed multi-national project teams, as well as external collaborations● Approval of two New Project Proposals● Successful submission of 3 INDs● Management of projects totaling $14.4 MM within approved budgets and time lines● HIV vaccine collaborations included the NIH, Walter Reed Army Hospital, Pasteur Merieux Connaught, Thailand Ministry of Public Health, and Aids Vaccine Awareness Coalition

Directed the intramural and extramural antiviral research efforts, focusing on the development of small molecules (including cyclocreatine) as antiviral agents for CMV retinitis in AIDS patients. Supervised 3 Research Associates and performed anticancer experiments using creatine analogs.

Investigated the link between hepatocellular carcinoma, hepatitis B, and myc oncogenesAdvisor: Don Ganem